Clinical Trials Logo

Clinical Trial Details — Status: Recruiting

Administrative data

NCT number NCT06036862
Other study ID # GIHSYSU-TLCAS
Secondary ID
Status Recruiting
Phase N/A
First received
Last updated
Start date August 1, 2023
Est. completion date December 31, 2026

Study information

Verified date September 2023
Source Sun Yat-sen University
Contact Liang Huang, Doctor
Phone 15989101216
Email huangl75@mail.sysu.edu.cn
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

Severe rectal anastomotic stenosis can not only cause intestinal obstruction, but also be accompanied by frequent defecation, which affects the quality of life, and patients face the outcome of permanent stoma or temporary stoma again. Traditional transabdominal resection and reconstruction of rectal anastomotic stenosis is more likely to occur due to unclear anatomical structure, dense scars around the intestinal canal, complications such as ureteral and urethral injury and massive presacral hemorrhage. In addition,41%of patients with anastomotic stenosis who underwent reoperation through abdominal surgery had anastomotic leakage again, and up to 30% of patients could not close the stoma. The advantages of transanal total mesorectal excision (taTME) using a transanal approach for total mesorectal excision in the treatment of middle and low rectal cancer with difficult pelvis have been demonstrated by our group. However, taTME has rarely been explored in the treatment of anastomotic stenosis. Our team retrospectively summarized the patients who underwent transabdominal transanal endoscopic resection and reconstruction of anastomotic stenosis (l-taTME), and initially demonstrated the safety and effectiveness of this surgical method, with a stoma closure rate of 90%. Although the advantages of l-taTME in the treatment of severe rectal anastomotic stenosis are obvious in theory and preliminary clinical practice, there is a lack of prospective studies. Therefore, the investigators plan to conduct a prospective clinical study to observe the safety and efficacy of l-taTME reconstruction surgery, and to provide high-level evidence-based medical basis for the selection of resection and reconstruction surgery for patients with rectal anastomotic stenosis.


Description:

Read more »
Read more »

Study Design


Related Conditions & MeSH terms


Intervention

Procedure:
Transanal and transabdominal combined endoscopic resection of rectal stenosis and anal reconstruction
Laparoscopic or open surgery was selected according to the patient's condition, surgical history and surgeon's experience.According to the extent of the rectal stenosis, the proximal colon was dissected.A circular incision was made above the dentate line and the broken end was sutured. After the intestinal cavity was closed, a single port was inserted through the anus, and a transanal endoscopic platform was established after pneumoperitoneum infusion.The stenotic and scar segments were removed free upward.Through the pelvic cavity and into the abdominal cavity from the bottom up. The narrow rectum and proximal colon were pulled out of the anus through the anus, and the diseased bowel was removed. According to the distance of the remaining distal rectum, stapler or manual anastomosis or Bacon operation was selected.

Locations

Country Name City State
China Sixth Affiliated Hospital of Sun yat-sen University Guangzhou Guangdong

Sponsors (1)

Lead Sponsor Collaborator
Sun Yat-sen University

Country where clinical trial is conducted

China, 

References & Publications (20)

See more »

Outcome

Type Measure Description Time frame Safety issue
Primary Stoma recovery rate whether the stoma recovery and restoration of bowel continuation 3 months after surgery
Secondary incidence of postoperative anastomotic leakage whether the occurence of anastomotic leakage 1 month after surgery
Secondary incidence of postoperative anastomotic bleeding whether the occurence of anastomotic bleeding Duration of 7 days after surgery
Secondary Incidence of severe bowel dysfunction Low Anterior Resection Syndrome Score (0-20: No LARS 21-29: Minor LARS 30-42: Major LARS) 3 months after stoma recovery
Secondary Incidence of severe bowel dysfunction Low Anterior Resection Syndrome Score (0-20: No LARS 21-29: Minor LARS 30-42: Major LARS) 6 months after stoma recovery
Secondary Incidence of severe bowel dysfunction Low Anterior Resection Syndrome Score (0-20: No LARS 21-29: Minor LARS 30-42: Major LARS) 1 year after stoma recovery
Secondary Incidence of severe bowel dysfunction Low Anterior Resection Syndrome Score (0-20: No LARS 21-29: Minor LARS 30-42: Major LARS) 2 years after stoma recovery
Secondary Anorectal function Anorectal pressure Rectal sensory function Rectoanal reflex function 1 year after stoma recovery
Secondary Anorectal function Anorectal pressure Rectal sensory function Rectoanal reflex function 2 year after stoma recovery
Secondary bowel function Memorial Sloan-Kettering Cancer Center bowel function instrument 3 months after stoma recovery
Secondary bowel function Memorial Sloan-Kettering Cancer Center bowel function instrument 6 months after stoma recovery
Secondary bowel function Memorial Sloan-Kettering Cancer Center bowel function instrument 1 year after stoma recovery
Secondary bowel function Memorial Sloan-Kettering Cancer Center bowel function instrument 2 year after stoma recovery
Secondary Quality of life evaluation after stoma closure European Organization for Research and Treatment of Cancer QLQ-C30 (0-100 0:poor 100:best) 3 months
Secondary Quality of life evaluation after stoma closure European Organization for Research and Treatment of Cancer QLQ-C30 (0-100 0:poor 100:best) 6 months
Secondary Quality of life evaluation after stoma closure European Organization for Research and Treatment of Cancer QLQ-C30 (0-100 0:poor 100:best) 1 year
Secondary Quality of life evaluation after stoma closure European Organization for Research and Treatment of Cancer QLQ-C30 (0-100 0:poor 100:best) 2 years
Secondary Quality of life evaluation after stoma closure European Organization for Research and Treatment of Cancer QLQ-C30 (0-100 0:poor 100:best) 3 years
Secondary Inraoperative condition operation time and whether to convert to laparotomy In the process of operation
Secondary Perioperative recovery time Duration of analgesics in hours For the first time the exhaust time in hours Time to first defecation in hours Time to first fluid intake in hours Time to resume normal diet in hours Abdominal drainage tube removal time in days Catheter removal time in days Length of postoperative hospital stay in days perioperative period
See also
  Status Clinical Trial Phase
Terminated NCT04406428 - NKI Therapy Compared to Usual Care of Recurrent Esophagogastric Anastomotic Strictures N/A
Recruiting NCT03229655 - Evaluation of Sequential Stent Addition vs. Incremental Dilation & Stent Exchange for Management of Anastomotic Biliary Strictures After Liver Transplantation N/A
Recruiting NCT04613635 - Stratafix vs. Vicryl OAGB / MGB Suture Study N/A
Not yet recruiting NCT03999008 - Oral Viscous Budesonide in Anastomotic Stricture After Esophageal Atresia Repair (OVB in EA) N/A
Completed NCT06404554 - A Prediction Model of Anastomotic Stricture After Rectal Cancer
Withdrawn NCT04037072 - Efficacy of Topical Mitomycin C for Complex Benign Esophageal Anastomotic Strictures Phase 2
Recruiting NCT03910699 - THREE-row Circular STAPLER in Low Anterior Resection for Rectal Cancer N/A
Recruiting NCT06348381 - Prediction of Anastomotic Complications and Recurrent Laryngeal Nerve Injury Based on Postoperative Early Endoscopic Evaluation